Evidence map›Paper›PMID 36536241›Full record

ArticleNature neuroscience2023

Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration.

Sean K Ryan, Matija Zelic, Yingnan Han, Erin Teeple, Luoman Chen, Mahdiar Sadeghi, Srinivas Shankara, Lilu Guo, Cong Li, Fabrizio Pontarelli and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Nature neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 228 papers.

0numbers the graph read from it
0cells of the map it votes in
228citing papers in PubMed
25.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

228 citing papers in PubMed, 315 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

168 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 2 countries.

Sean K RyanSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
Matija ZelicSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
Yingnan HanSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6356-4052
Erin TeepleSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Luoman ChenSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Mahdiar SadeghiSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Srinivas ShankaraSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Lilu GuoSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Cong LiSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Fabrizio PontarelliSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
Elizabeth H JensenSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
Ashley L ComerSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
Dinesh KumarSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Mindy ZhangSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Joseph GansSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Bailin ZhangSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Jonathan D ProtoSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
Jacqueline SalehSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
James C DodgeSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
Virginia SavovaSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Deepak RajpalSanofi, Precision Medicine and Computational Biology, Cambridge, MA, USA.
Dimitry OfengeimSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA.
Timothy R HammondSanofi, Rare and Neurologic Diseases, Cambridge, MA, USA. timothy.hammond@sanofi.com.ORCID http://orcid.org/0000-0001-7761-6362
Sanofi (United States) · USSanofi (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron dysregulation has been implicated in multiple neurodegenerative diseases, including Parkinson's disease (PD). Iron-loaded microglia are frequently found in affected brain regions, but how iron accumulation influences microglia physiology and contributes to neurodegeneration is poorly understood. Here we show that human induced pluripotent stem cell-derived microglia grown in a tri-culture system are highly responsive to iron and susceptible to ferroptosis, an iron-dependent form of cell death. Furthermore, iron overload causes a marked shift in the microglial transcriptional state that overlaps with a transcriptomic signature found in PD postmortem brain microglia. Our data also show that this microglial response contributes to neurodegeneration, as removal of microglia from the tri-culture system substantially delayed iron-induced neurotoxicity. To elucidate the mechanisms regulating iron response in microglia, we performed a genome-wide CRISPR screen and identified novel regulators of ferroptosis, including the vesicle trafficking gene SEC24B. These data suggest a critical role for microglia iron overload and ferroptosis in neurodegeneration.

Indexed as

FerroptosisInduced Pluripotent Stem CellsIron OverloadParkinson DiseaseHumansIronMicrogliaVesicular Transport ProteinsIronSEC24B protein, humanVesicular Transport Proteins

Identifiers

PMID36536241
PMCPMC9829540
OpenAlexW4312114253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.